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THREE-DIMENSIONAL BODY SCANNING: A NOVEL 
TECHNIQUE FOR BODY COMPOSITION ASSESSMENT 
Justin Ryder 
Dr. Steve Ball, Thesis Supervisor 
ABSTRACT 
INTRODUCTION: Accurate body composition assessment is crucial for determining 
health consequences due to excess body fat (BF). While several techniques exist there are 
few that are accurate, non-invasive, fast, and comfortable for subjects. The Three 
Dimensional (3D) body scanner is a new body composition assessment method that 
might serve as another option for investigators and practitioners. The purpose of this 
study was to determine the accuracy of the 3D body scanner at measuring body 
composition using dual energy x-ray absorptiometry (DXA) and Air displacement 
plethysmography (Bod Pod) as criterion measures. The 3D body scanner was evaluated 
on its ability to work with differences in normal versus overweight subjects as 
determined by BMI.  Also, a new prediction equation was created and compared to that 
of an existing equation used by the 3D body scanner developed by the Department of 
Defense (DoD).  
 
METHODS: Eighty-Five male subjects (21.70 ± 2.28 yr old; 81.00 ± 12.21 kg; 25.37 ± 
3.40 kg/m
2
) completed all body composition assessment techniques on the same day. 
Tests preformed included: DXA, Bod Pod, and 3D body scanning. Subjects did not eat or 
drink 2 hr previous to testing and did not exercise 4 hr previous to testing. Data was 
analyzed using SPSS version 17.0. Bland-Altmand plots, Pearson correlations, and a one-
way ANOVA comparing means were performed. A prediction equation (3D MU) was 
created using a stepwise regression based on correlation to DXA.  
 
RESULTS: Mean comparison of body composition techniques were as follows: DXA 
BF 16.30 ± 4.67; Bod Pod 12.17± 7.19; DoD 13.53 ± 6.43; 3D MU 16.49 ± 4.16. 3D MU 
had a SEE=3.09 over the entire sample compared to DoD SEE=3.67 and Bod Pod 
SEE=2.45. Although body volumes of Bod Pod and 3D Scanner were highly correlated (r 
= 0.984; p =0.001), the 3D Scanner underestimated body volume. Improvement in 
making consistent estimations of head, hand, and feet are necessary for the 3D body 
scanner to be used for body composition assessment.  
 
CONCLUSION: Although the 3D body scanner shows promise as a method of 
evaluating BF, more work is needed before it can be considered an acceptable laboratory 
method of assessment. A 3D MU prediction equation was created that appears to be more 
accurate for young men than the current DoD equation. 3D body scanning shows 
potential as a method for determining body composition in overweight subjects. 
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INTRODUCTION 
Body composition is the specific amount of adipose tissue, muscle tissue, and 
bone present in the body.  Although not technically correct, most often the term is used to 
represent only the amount adipose tissue or percentage of body fat (BF) present.  High 
amounts of adipose tissue or BF have been shown to be detrimental to one’s health and 
increased disease risk (1, 58-59, 78-79, 88).  Obesity, which is defined as having excess 
BF (69), is a leading cause of hypertension, hyperlipidimia, and type II diabetes (6, 18, 
59, 82, 96).  These conditions are two to three times more prevalent in obese individuals 
according to the National Institutes for Health (37).  Understanding and accurately 
measuring BF is a valuable resource for fitness and health professionals. Accurate BF 
assessment is needed in order to assess health risk, monitor change in BF with certain 
diseases, to formulate dietary recommendations and exercise prescription, to estimate 
ideal body weight of clients and athletes, and to monitor growth, development, 
maturation, and age related changes in body composition (39).   
The basic theoretical model of body composition is the two compartment model 
(2C). The 2C model divides the body into two categories: fat mass (FM) and fat-free 
mass (FFM). FM consists of all extractable lipids from adipose and other tissues, while 
FFM includes all residual chemicals and tissues ( i.e., water, muscle, bone, connective 
tissue, and internal organs) (56).  This theoretical two compartment model is the most 
basic model of body composition and has been the foundation for estimating BF.  The 2C 
model is the basis for popular assessment techniques such as hydrostatic weighing (HW) 
(26), air displacement plysmography (Bod Pod), (8, 21) and skinfolds (27, 56).  
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Multicompartment models (3C, 4C, 5C) add additional accuracy by measuring one or 
more constituents of the FFM.  For example, Dual Energy X-Ray Absorptiometry (DXA) 
measures bone density making it a 3C model of body composition. Unfortunately, the 
cost and difficulty of using multicompartmental models, especially 4C and 5C, limit their 
use in most settings.   
Choosing the most accurate method of BF assessment most often depends on 
accessibility to equipment. Although, laboratory methods (DXA, HW, and Bod Pod) are 
considered to be the most accurate assessments, unfortunately most practitioners do not 
have access to these techniques (24, 76, 85, 95, 97).  Field methods, which are accessible 
to most professionals, include Body Mass Index (BMI), skinfolds (SKF), anthropometric 
measurements, and bioelectrical impedance (BIA) (7-9, 40, 72).  Most practitioners are 
forced to use field methods due to their availability and cost.  Therefore it is critical that 
researchers continue to improve the accuracy of these methods.   
Field Methods 
Body Mass Index. Weight-for-height ratios, such as BMI, are often used in 
clinical and epidemiological studies as substitute measures of BF.  Although a crude 
measure, BMI is fast, easy, cost effective and requires little technician skill. The 
American College of Sports Medicine (ACSM) defines a BMI of greater than or equal to 
30 kg/m
2
 as obese and a BMI between 25 and 29.9 kg/m
2
 as overweight (69).  While this 
is the simplest and easiest field method of assessing ones risk it does not take in account 
muscle mass which makes it a less effective method of assessing risk.  Thus, better 
methods are needed in order to accurately assess risk based upon BF.   
3 
 
Skinfolds.  SKF are among the most popular field method of assessing BF (27, 
43-45).  SKF measure subcutaneous adipose tissue deposits in various site specific areas.  
SKF predict BF by using regression equations based on the subcutaneous fat folds, age, 
and gender.  Since SKF testing is easy to administer and low in cost, it is ideal for large-
scale epidemiological studies (49).  There are several sources of measurement error 
which include technician’s skill, type of SKF caliper, subject factors (hydration status, 
previous exercise, pliability of subcutaneous fat) and the prediction equation used.  
Variability among technicians is also a major source of error.  Approximately 3% to 9% 
of the variability in SKF measurements can be attributed to the difference between 
technicians (57, 73). Nevertheless, SKF are a practical way to measure BF in the field. 
Compared to Laboratory methods, SKF can predict BF with a total error of 
approximately 2-3% (8-9, 34) and are considered an acceptable means to measure and 
track BF in the field (9, 34, 47). 
Bioelectrical impedance.  A popular alternative field method to SKF is BIA. BIA 
is a simple and fast method of establishing the amount of FFM a person possesses (60, 
84).  The device commonly uses electrodes that attach at the wrist and ankle.  A small 
electrical current is sent between electrodes and the resistance to flow or impedance is 
measured. BIA uses the principle that lean tissue has a greater electrolyte and water 
content than fat.  As a result, water has less impedance than fat (15).   Tissues that 
contain high amounts of water and electrolytes such as cerebrospinal fluid, blood, or 
muscle are highly conductive whereas fat, bone, and air-filled spaces such as lung are 
highly resistant (2).  Precision in using BIA can be obtained as long as standardized 
procedures are followed.  Most importantly hydration status must be normal.  In healthy 
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subjects, the majority of factors that affect hydration status are controllable, such as 
recent exercise, liquid intake, and stage of menstrual cycle (11).  Variations in ambient 
temperature can also affect BIA and therefore should be considered if BIA is selected as 
the field method of choice (11, 19).  Body positioning can also alter results since 
gravitational effects can cause fluid redistribution. Subjects should lay supine and on a 
nonconductive surface (36).  Time spent in the supine position must also be standardized.  
Compared to laboratory methods BIA can predict BF with a total error of approximately 
4-10% (28, 38, 75, 81, 91), giving the device high variability. 
Although not as accurate as laboratory methods, field methods are critically 
important to practitioners and serve an important role in body composition assessment. 
However, when accessible, laboratory methods should be chosen over field methods due 
to their increased accuracy and reliability. There are several popular laboratory methods 
currently available.  
Laboratory Methods 
Hydrostatic weighing.  HW has often been considered the “gold standard” 
method of body composition assessment techniques (23).  HW uses Archimedes’s 
principle to determine total body volume and thus density by measuring the difference 
between a subject’s weight in water and that in air (12).   HW is considered to be the 
original and most acceptable 2C model. In lay terms, since fat is less dense than water, it 
floats while lean body tissue (muscle and bone) is denser than water, and thus sinks.  
While HW is an acceptable laboratory method, it has several methodological issues, 
including: subject position, determining residual volume, number of trials, comfort level 
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in water, and head placement (14, 26, 77, 90, 99-100).  Recently, HW has lost favor due 
to in part to its complicated procedure but mostly because more technologically advanced 
methods have been developed.   
Bod Pod.  Air displacement plethysmography, commercially known as the Bod 
Pod, is a 2C model that determines body volume by measuring the amount of  air 
displaced by the body (7, 21, 31).   Body density (BD) and thus BF can be determined 
using the Siri equation (86).  The Bod Pod is widely used in laboratories due to its ease of 
use, speed, and portability.  The Bod Pod tends to accurately measure BF compared to 
other laboratory methods (8, 13, 61).  Bod Pod is not without drawbacks however. 
Subjects must wear minimal clothing which may be uncomfortable for some subjects 
(31).  A thoracic lung volume must also be assessed and some subjects have difficulty 
with the required breathing procedure. Nevertheless, the Bod Pod is a popular laboratory 
method that has replaced HW in many settings.   
Duel X-ray absorbtometry.  DXA is a 3C model that measures bone mineral 
density, lean body mass, and fat mass.  DXA has been shown to be an effective, easy, and 
safe method of assessing body composition across populations (8).  Although DXA uses 
radiation the dosage is very low (<5 mrem) (9) and therefore many researchers refer to it 
as the new “practical gold standard” of body composition assessment (3, 4).   While there 
are many advantages of DXA (speed, accuracy, ease of use), it is limited in its use due to 
its high cost and accessibility.  Thus it is relegated to laboratory use and is not a practical 
method for mass testing.  Due to DXA’s high cost some research facilities have turned to 
a different technology, air displacement plethysmography, to assess BF.  In fact, DXA 
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has replaced HW as the “gold standard” in body composition assessment (5, 50-51, 89, 
98). 
Although there are several acceptable Laboratory methods available (HW, DXA, 
Bod Pod), body composition researchers and practitioners alike are constantly searching 
for more accurate, unproblematic, and cost effective methods of determining BF. The 
assessment techniques discussed above will continue to be used by researchers and field 
professionals until a new method emerges that is accurate, quick, easy to perform and 
cost effective.  One possible technique might be Three-dimensional (3D) body scanning. 
Three-dimensional body scanning.  The 3D body scanner was originally 
developed to be used in the apparel industry. Body scanners use light to illuminate an 
object, or in this case the human body, while a series of cameras capture reflected light 
resulting in a detailed digital 3D image.  The scanner allows for linear, two- dimensional 
and three-dimensional measurements of the body’s surface.  The body measurements are 
very precise and are much more accurate than typical anthropometric measurements 
determined by tape measures, sliding calipers, and other devices (33).  More importantly, 
since the scanner measures total body volume, BF should be able to be predicted by 
calculating body density. The scanner is thus a 2C model that might have promise as 
another method of BF assessment. The scanning procedure is very fast (5 seconds) and 
completely non-invasive which allows for mass testing.  
 No one has yet compared 3D scanner produced percent BF to DXA or any other 
laboratory method.  Previous studies by the United States Department of Defense (DoD) 
have looked at using 3D body scanning as a novel, effective method of assessing body 
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composition (33). However, instead of using body volume to calculate density and thus 
fatness, they used circumferences to predict BF.  Comparing BF of 37 white males 
attained from DXA and 3D body scanning, linear regression analysis from 
circumferences revealed moderate and statistical significance (p<0.05) and Pearson 
correlation coefficients with moderate standard errors (R
2
=0.74, SEE= 3.3).  Generally, 
using circumferences as a measure of BF is considered to be a crude measure with much 
variability (27, 41, 55).  In fact, the study was not published.  Currently, no one has 
compared 3D scanner produced percent BF from body volume to DXA or any other 
laboratory method.   
In a pilot study, the current researchers found body volume from the 3D scanner 
to be highly correlated to that of Bod Pod body volume (R
2
 = 0.79) in a group of 27 men.  
As previously stated, body volume can be converted to body density (Mass (kg)/ Volume 
(L)) and using the Siri equation (BF= (495 / Body Density) – 450) BF can be determined.  
More data needs to be collected in order to compare 3D scanner BF to a criterion measure 
such as DXA.  
Purpose.  The purpose of this study is to determine if 3D body scanning can be 
used as an accurate method of body composition assessment.  Scanner BF will be 
compared to DXA BF.  If a regression equation needs to created in order to better 
determine BF, the new regression equation will be compared with the DoD equation to 
determine which has a lower error.  Additionally, 3D body scanning body volume will be 
compared with Bod Pod body volume to help determine where the error, if any, may 
exist. It is hypothesized that 3D body scanning will be as accurate as other 2C models 
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(Bod Pod) at predicting BF compared to DXA.  Also, the 3D body scanner will be 
evaluated on its ability to work with differences in normal versus overweight subjects as 
determined by BMI. 
METHODS 
Subjects.  97 male subjects were recruited for the study and 85 were used for 
final analysis.  Subjects were between the ages of 18-30 years old were recruited to 
participate in this study.  All participants were informed of the procedures and risks of the 
study prior to participation.  All subjects signed an informed consent form in accordance 
with the policies and procedures of the University of Missouri Human Subjects 
Institutional Review Board.  
 Subject preparation.  Subjects were instructed not to eat or consume water 2 hr 
previous to testing.  Subjects were asked to refrain from exercise 4 hr prior to testing.  
Subjects removed all jewelry and wore non-metallic or plastic clothing.  Subjects wore a 
swim cap and were measured in their underwear or small shorts for the Bod Pod.  
Subjects wore shorts only for anthropometric measurements.  In the 3D body scanner 
subjects wore grey boxer briefs.  For the remainder of the tests subjects wore shorts and a 
T-shirt.  All tests were completed on the same day within 2 hrs of each other.  Testing 
order for each subject will be as follows: height, body weight, DXA, Bod Pod, 
anthropometric measurements, hand volume, foot volume, and 3D body scanning.   
Anthropometric Measurements. Anthropometric measurements were taken 
following American College of Sports Medicine guidelines (69).  Subject’s body weight 
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was taken to the nearest 0.5 lb using (Toledo scale, Mettler-Toledo Inc., Columbus, OH, 
USA) and height were measured to the nearest 0.25 inch using (Seca 216, Seca gmbh & 
co. kg., Hamburg, Germany).  Circumference of the waist (narrowest point between the 
umbilicus and rib cage) and hip (largest protrusion of the buttock) were taken to the 
nearest 0.5cm using a Medco Tape Measure (Medco Sports Medicine, Tonawanda, NY, 
USA).  Body mass index (BMI; kg/m
2
) and waist to hip ratio (WHR) was calculated as 
descriptive data.   
DXA.  Body composition was assessed with DXA (QDR 4500A, Hologic, Inc., 
Bedford, MA, USA) using fan beam technology.  The subjects wore minimal clothing 
and removed all metal objects before being scanned.  Subjects laid supine on the DXA 
table and were manually positioned by the researcher to manufacture specification.  
Subjects were scanned once.  Body composition was estimated using computer software 
(QDR Software for windows XP, Version 12.4, Hologic, Inc., Bedford, MA).  Bone 
mass, fat mass, and lean tissue mass were represented in grams.  BF was calculated by 
software that represented fat mass (g)/ total mass (g) x 100. 
Three-Dimensional body scanner.  Body scans were collected on all subjects using 
Textile/Clothing Technology Corp. ([TC]²),  3D body scanner (Cary, NC, USA).  
Subjects were instructed to remove all clothing and jewelry.  Subjects wore only gray 
knit cotton undershorts while in the scanner.  A 3D body image was created using [TC]² 
body imaging software.  Subjects were required to remain in the 3D body scanner until a 
good body image was output by the software.  From the body image a bulk body volume 
was obtained.  Bulk volume removes hands, head, and feet from the total volume.  In 
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addition to comparing BF from the scanner to BF via DXA, the [TC]² fitness 
equation(33), created by the DoD, was compared to BF by DXA.  All scans were 
conducted by the same trained technician.  
Head, hand and foot volume.  Since the 3D body scanner cannot effectively 
measure head, hands, or foot volume, these measures were obtained independently in 
order to accurately determine if they are needed in assessing total body volume.   
Hand volume was measured by water displacement using a volumeter. Subject’s 
wrists were marked at the wrist (articulatio radiocarpea) joint. Subjects were instructed to 
slowly lower their wrists into the water, as to avoid splashing.  Subjects held their arm 
steady; water overflow was monitored until the overflow was slowed by more than 2 sec 
between overflow water drops.  Displaced water was then measured to the nearest 5 ml 
using a graduated cylinder.  
 Foot volume was measured using water displacement using a volumeter.  
Subject’s feet were slowly lowered into water with the researcher’s assistance until the 
water reached the ankle (talofibrial) joint at the mid-point of the lateral malleolus and 
held their leg steady until water overflow was slowed by more than 2 sec between drops.  
The amount of displaced water was then measured in order to obtain an accurate volume 
of the object place in the water (12, 42, 86).   
Head volume was estimated using anthropometric measurements of head length 
and head circumference.  The two measures was placed into a regression equation 
developed by McConville et al (66).  The accuracy of the equation is acceptable (R = 
0.798; SEE 4.2%).  
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Bod Pod.  Body Composition was assessed using the Bod Pod (Life 
Measurements, Inc., Concord, CA, USA) in order to compare the BF from Bod Pod to 
that of the 3D body scanner.  The Bod Pod is a dual chambered air-displacement 
plethysmograph that employs the densitometric approach to assess body composition.  
Subject mass was measured using an electronic scale, attached to the Bod Pod, which was 
calibrated to within ± 0.05%.  Subject body volume was measured in an enclosed 
chamber using the relationship between pressure and volume.  Chamber air volume was 
determined both with and without a subject in the test chamber, with the difference 
between the two measures yielding the subject’s body volume.  Body volume was 
measured at least twice and possibly three times if the first two measurements were not 
within 150ml or 0.3%.  If no two measures met the acceptance criteria for a subject, the 
entire test procedure was repeated.  Body volume was corrected for thoracic gas volume 
in the lungs via a prediction equation (67). BF was derived by using the two-
compartment Siri equation (61, 67, 86).  All calculations were performed by the Bod 
Pod’s software (version 1.91). 
Statistical Analysis.  SPSS version 17.0 was used for statistical analysis.  Pearson 
correlation and coefficient of determination, R
2
, were assessed in order to determine the 
reliability of the measures. Standard estimation of error (SEE) was used in order to assess 
the quality of the regression equation created.  DXA was used as the criterion measure of 
body composition assessment to which scanner and Bod Pod BF was compared.  
Reliability.  For the DXA, 3D body scanner, and Bod Pod each test was 
performed twice on 10 subjects on the same day in order to assess reliability. .  
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RESULTS 
 Ninety-seven male subjects were recruited for the study and 85 were used for 
final analysis.  Table 1 shows subject characteristics with outliers removed.  Outliers 
were determined to be ± 3 standard deviations from the mean using 3D body scanner BF 
(3D SCAN) as the method of evaluation.  Percent BF via DXA, Bod Pod, 3D SCAN, and 
the scanner’s current prediction equation developed by the Department of Defense (DoD) 
are compared in Table 2.   3D SCAN and Bod Pod BF were computed using the Siri 
equation (16, 86).  A new prediction equation using 3D body scanning was also 
computed using a DXA correction factor equation labeled 3D MU (Table 2). 
Table 1. Subject characteristics.
Mean ± SD Range
n 85
age (y) 21.7 ± 2.3 18-30
Height (M) 1.7 ± 0.7 1.41-1.96
Weight (kg) 81.0 ± 12.2 56.1 - 127.1
BMI (kg/M
2
) 25.37 ± 3.40 19.38 - 40.77
Waist Circumfrence (cm) 82.2 ± 8.7 63.1 - 122.3
Hip Circumfrence (cm)  97.9 ± 6.6 84.3 - 120.8
WHR 0.84 ± 0.06 0.60 - 1.01
BMI = body mass index
WHR = waist-to-hip ratio   
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Table 2. Body composition comparisons.
Mean ± SD Range Mean diff. from DXA
n 85
DXA BF  16.30  ± 4.67 8.20 - 32.80
Bod Pod BF 12.17 ± 7.19 1.23 - 37.68 |-4.13
3D SCAN BF † 9.60 ± 12.22 |-15.11 - 53.89 |-6.70
DoD BF* 13.53 ± 6.43 5.35 - 54.45 |-2.77
3D MU BF  16.49 ± 4.16 11.03 - 31.73 |0.19
*Based upon the Department of Defense equation used by the [TC
2
] Software (23)
† 3D Body Scanner BF using Siri equation  
Inter-method body composition comparisons 
 Body composition correlations using DXA as the criterion are shown in Table 3. 
Figures 1, 2, 4, and 5 represent the correlation of DXA BF with 3D SCAN, 3D MU, Bod 
Pod, and DoD respectively.  Figure 3 represents correlation for 3D MU BF to Bod Pod 
BF.   
Table 3. Correlations of body composition methods to DXA.
Pearson Correlation
Bod Pod BF 0.856 **
3D SCAN 0.237 *
DoD 0.629 **
3D MU 0.759 **
**  Denotes significance at 0.01 level
* Denotes significance at 0.05 level  
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Figure 1. Correlation of 3D SCAN to DXA.
Adj. R
2
 = 0.045
SEE = 4.59
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Figure 2.  Correlation of 3D MU to DXA.
Adj. R
2
 = 0.571
SEE = 3.09 
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Figure 3. Correlation of 3D MU to Bod Pod.
Adj R
2
= 0.515
SEE = 2.89
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Figure 4. Correlation of Bod Pod to DXA.
Adj. R
2
= 0.729
SEE = 2.45 
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Figure 5. Correlation of DoD to DXA.
Adj. R
2
 = 0.388
SEE = 3.67 
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Body volume comparisons 
 Table 4 represents the comparisons of body volume taken via the Bod Pod versus 
that of the 3D SCAN.  The Bod Pod measures volume in liters (L), while the 3D body 
scanner measures volume in cubic feet (ft
3 
) which was converted to L for comparison.  
Figure 6 graphically compares the Bod Pod and 3D SCAN volumes. 
Table 4.  Body volume comparisons.
Mean + SD Pearson Correlation
Bod Pod volume (L) 75.18 ± 11.65
3D SCAN volume (L) 74.85 ± 11.14 0.984**
**  Denotes significance at 0.01 level  
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Figure 6. Comparison of 3D SCAN volume to Bod Pod volume.
Adj. R
2
 = 0.969
SEE = 2.06 
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Development of the 3D MU correction equation 
 Table 5 shows the 3D MU correction equation created from a random samples of 
60 subjects and then cross validated on the remaining 25 subjects.  Predictors in the 
correction equation were determined via stepwise regression based upon the correlation 
to DXA.  Abdominal circumference determined by the scanner combined with 3D SCAN 
explained the most variance with the least amount of error.   
Table 5. Correction equation using randomly assigned groups of 60, cross validated by 25.
Group 1 (n  = 60)
DXA BF 16.41 ± 4.93
3D MU correction equation |-20.361 + 1.018 (abSCAN) + 0.052 (3D SCAN)|
3D MU BF (n  = 60) 16.54 ± 4.26, r2 adj = 0.695 SEE 2.77
Cross vadlidation (n  = 25) 16.39 ± 4.00, r2 adj = 0.679 SEE 3.32
abSCAN = Abdominal measurment from 3D body scanner
3D SCAN = Siri equation estimated BF from 3D body scanner
 
 Figure 7 is a Bland-Altman plot illustrating the underestimation of the 3D SCAN 
compared to DXA. Figure 8 is a Bland-Altman plot comparing DXA and the 3D MU BF.   
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Figure 7. Bland-Altman plot (Differences against mean of BF) for DXA versus 3D SCAN.
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Figure 8. Bland-Altman plot (Differences against mean of BF) for DXA versus 3D MU.
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Comparison of BMI Groupings 
 Table 6 shows a comparison of DXA BF, Bod Pod BF and 3D MU BF when the 
sample is divided into two groups based upon BMI norms.  BMI ≤ 25 were considered to 
be normal and BMI ≥ 25.1 were considered overweight. Both groups were both 
significantly correlated (p = 0.01) to DXA.  
Table 6. Body composition comparisons, normal versus overweight based upon BMI.
Mean ± SD Range Pearson Correlation to DXA
Normal (BMI ≤ 25) n = 43
BMI 23.06 ± 1.58 19.38 - 24.99
DXA BF 13.96 ± 2.63 8.20 - 24.99
Bod Pod BF 8.58 ± 4.21 1.23 - 20.98 0.526**
3D MU BF 14.16 ± 2.11 11.03 - 19.76 0.481**
Overweight (BMI ≥ 25.1) n = 42
BMI 27.90 ± 2.94 25.14 - 40.77 
DXA BF 18.76 ± 5.21 9.80 - 32.80
Bod Pod BF 16.22 ± 7.63 5.38 - 37.68 0.924**
3D MU BF 19.1 ± 3.85 11.93 - 31.73 0.707**
** Denotes significance at 0.01 level  
Comparison of anthropometric measurements  
 Table 7 shows anthropometrics measures of the waist and hip compared to the 3D 
body scanner.   
Table 7. Comparison of anthropmentric measures and 3D body scanner.
Mean ± SD SE Range
Waist anthropometric 82.32  ± 8.66 0.95 122.30 - 63.10
Waist Scan 86.77 ± 8.14 0.88 126.43 -72.57
Hip anthropometric 97.94  ± 6.51 0.71 120.80 - 84.30
Hip Scan 103.02 ± 6.33 0.69 129.61 - 91.05
*All measurements are (cm)   
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Reliability of measures 
 Table 8 shows the reliability of DXA, Bod Pod, and 3D SCAN on 10 subjects 
repeated twice. 
 
Table 8. DXA reliability, Bod Pod reliability, and 3D body scanner reliability
Reliability of body composition methods, n  = 10 repeated twice on same day
         correlations Paired T-Test
method r P mean diff. SEM t P
DXA 0.997 <0.001 0.1000 0.0538 1.861 0.960
Bod Pod 0.993 <0.001 0.1400 0.2342 0.598 0.565
3D body scanning 0.922 <0.001 0.0899 0.1101 0.817 0.435
Accept null hypothesis for all (means are equal)  
 
 
DISCUSSION 
The 3D body scanner shows promise as a fast, accurate, comfortable, and non-
invasive method of measuring body composition.  However, until now no study has 
investigated its accuracy compared to DXA.  It was hypothesized that 3D body scanning 
would be as accurate as other 2C models at predicting BF compared to DXA.  In its 
current form the 3D body scanner underestimates BF compared to DXA. However, the 
underestimation is consistent across BMI levels (Table 6) signaling the need for a new 
prediction equation to be created to account for the difference.  When the 3D MU 
correction equation was employed the 3D scanner appears to be as accurate as other 2C 
models (Bod Pod) at predicting BF. The 3D MU equation had a mean difference of 0.2% 
BF compared to DXA with a low SEE of 2.77 (Table 5). According to Lohman’s (53) 
subjective rating scale, the 3D scanner would score as a “very good” to “excellent” 
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method of estimating BF.  Further, the 3D MU equation would meet Lohman’s (13-14) 
standard acceptability criteria outlined for cross validating equations. 
Comparison of 2C models (Bod Pod and 3D Scanner) to DXA  
DXA was chosen as the criterion method in part because it has shown to be a very 
reproducible method (~1% BF) (46).  In this study, DXA was found to be reliable with a 
mean difference of 0.1%BF between trials.  (n = 10; r = 0.997; p <0.001).  Many 
researchers also favor DXA over multicompent models because it is fast, easy, and can be 
used on wide variety of populations (5, 9-10, 50). DXA is currently called the “practical 
gold standard” of body composition assessment techniques and is widely used to compare 
other techniques against (5, 46-47, 84, 93).  
 In the current study both the Bod Pod and the 3D MU were significantly and 
similarly correlated to DXA (P=0.001). Previous studies comparing Bod Pod to DXA 
show that the Bod Pod is an acceptable laboratory method of body composition 
assessment (32).  Mean differences
 
in BF measured by the Bod Pod and DXA have 
varied but are similar (-3.9 to 1.7 % BF) (20, 52, 70, 83, 93).   The current study shows a 
mean difference between Bod Pod and DXA to be  -4.13% which is similar and 
consistent to previous findings by  Fields and Goran (30).  The fact that the current data 
comparing Bod Pod and DXA is similar to other findings helps determine where 
differences in 3D scanner BF might exist and allows for a comparison between a current 
acceptable 2C model (Bod Pod) and a possible new method of assessment (3D body 
scanner).  
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The 3D body scanner corrected by 3D MU correction equation had a mean 
difference of 0.2% BF and was significantly correlated to DXA (p = 0.01).  The 3D MU 
had a more similar mean and SD with less SE than Bod Pod compared to DXA.  The 3D 
scanner has several advantages over the Bod Pod; speed (~3 times faster), less subject 
cooperation is necessary, and minimal technician training required. Also, the 3D scanner 
doesn’t suffer from environmental changes. The Bod Pod is sensitive to changes in 
temperature, humidity, and pressure making it a finicky device (8, 31, 61).  Nevertheless, 
the Bod Pod has been through much scientific rigor making it a popular and accepted 
laboratory measure of body composition assessment for many different populations. 
Despite the current positive results, scanning technology for measuring fatness is in its 
infancy. Many more investigations must take place before the 3D scanner might be 
regarded as accurate, reliable, and worthy as the Bod Pod.  
Comparison of BMI groupings. 
Accurately measuring obese individuals has been a weakness of most body 
composition methods. Interestingly, 3D MU was as good at predicting BF as compared to 
Bod Pod in both normal and overweight subjects as defined by BMI (p = 0.01) using 
DXA as the criterion (Table 6). In fact, it   appears that the 3D body scanner may be more 
accurate at estimating BF in overweight subjects (Table X) If this proves to be true this 
could be an obvious advantage over other current technologies. The Bod Pod is a 
relatively small device with a height limit of ~ 6’6” and a weight limit of ~ 300lb. DXA 
has a weight limit of 275-350lb depending on the model.  In addition, many larger 
subjects are too wide to fit on the DXA scanning area. Whereas, the 3D body scanner is a 
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much larger area and could potentially measure almost any person regardless of height, 
weight or width. This is an area where future research is should focus. 
DoD versus 3D MU. 
The 3D MU correction equation shows a significant improvement over that of the 
original [TC2] BF estimation equation created by the DoD (34). The DoD equation 
significantly underestimated BF compared to DXA (2.8%). The DoD equation also had a 
much wider range (5.4 - 54.5%) compared to DXA (8.2 - 32.8%). BF by the DoD is 
determined by circumference measurements, which not surprisingly, typically do not 
accurately predict body fatness (86). Obviously, circumferences are not the most accurate 
means of determining BF since it is impossible to determine how much muscle or fat is 
underneath the skin. Typically BF predicted by circumferences has a very high error (20). 
Studies comparing this method to HW showed a 6.8 to 18% false positive rate for 
individuals declared as having excess body fat (86). In addition, research suggests 
circumferences are even less accurate for individuals with very low or very high BF (11). 
Our population consisted of leaner individuals (16.3% BF) and thus might further explain 
why the DoD equation did not accurate predict BF in this sample. It appears the 3D MU 
equation is a better alternative to the currently employed equation. When compared to 
DXA over the entire sample the mean difference of the DoD was 2.77% with a SEE 3.67 
compared to that of 0.2% with a SEE 3.09 using 3D MU equation. 
Limitation and sources of error. 
While there were 97 subjects that completed the study only 85 subjects were used 
for final statistical analysis or ~88% of total subjects.  Subjects removed from the data set 
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met two criterion: 1) they were ±3 SD from the mean of the 3D body scanner BF, and 2) 
they exhibited “influence” if not removed.  Influence was determined by using Cook’s D 
which is frequently used to calculate the leverage that specific cases may exert on the 
predicted value of the regression line (74).  While there were 12 outliers using 3D SCAN 
as the criterion, if the criterion was switched to DXA there were zero ouliers and if 
switched to Bod Pod there were 2 outliers (both of which were also outliers with 3D 
SCAN).  The variability with the 3D body scanner is higher than with other methods and 
needs to be improved upon in order for 3D body scanning to be a valid method of 
assessment in the future.  Examining standard protocol for 3D body scanning to make it 
consistent for each subject could help with limiting false positive readings.  Limiting the 
number of anomalous readings is of critical importance and an area that must be 
addressed by the manufacturer in order for this tool to be considered laboratory quality.  
It should be noted that other technologies, Bod Pod in particular, were not perfect the first 
time they were applied to body composition assessment (24, 32).  In fact, Bod Pod 
underwent many technology and software advances in order to become a valid tool for 
body composition assessment.  
One possible explanation for some of the strange results (outliers) is in the 
determination of body volume. Minor variations in volume will significantly alter density 
estimation and thus BF. Therefore it is critical that body volume is measured as 
accurately as possible with as little error as possible. While 3D body scanning body 
volume was highly correlated to Bod Pod body volume (r = 0.98; p= 0.01), with similar 
means (Table 4), there was a slight underestimation of volume. The underestimation of 
volume would explain the underestimate of BF by the 3D scanner compared to DXA.  
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Unfortunately, the 3D body scanner fails to give full volumes for the head, hands, and 
feet. Since scanning technology’s main use is to custom fit clothing there is no reason for 
the device to precisely measure these body parts. In fact, only part of the head, hands, and 
feet are shown in the scanner output (shown in pictures below).  
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Although the scanner attempts to determine a volume for these segments, it 
appears to a major limitation in determining total body volume.  Volumes of the head, 
hands, and feet were measured manually (Appendix D) and an attempt was made to add 
the combination of these volumes to total body volume via the scanner. However, the 
addition of these volumes increased total body volume to a very high value since the 
scanner is already partially measuring these body parts. Accurate determination of head, 
hands, and feet volume is an area that, if improved, might vault the 3D Scanner to the 
forefront of laboratory body composition assessment techniques. Without an 
improvement in this area, it is unlikely that the 3D scanner will replace currently 
employed methods.  
One finally source of error in determining body volume is the amount of hair on 
the head. The body scanner can only measure non-hair covered portions of the head.  
Individuals with significant amounts of hair will likely have additional underestimation 
of body volume and thus body fat.  Perhaps by wearing a swim cap this can be improved. 
We failed to account for this and recognize it as a limitation. Future researchers should 
consider this fact, especially if they work with populations that have considerable head 
hair. 
 Although questions about scanner body volume exist, the scanner appears to very 
reliable.  The 3D body scanner reliability testing (n = 10; r = 0.922 ;p <0.001), was 
consistent and similar to DXA and Bod Pod reliability data (8). Reliability is key factor 
for a technique to reach laboratory status. The fact that the 3D scanner is consistent is 
important and noteworthy.  [TC]2's 3D Body Measurement System uses a white light-
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based scanner and proprietary measurement extraction software. The scanner captures 
hundreds of thousands of data points of an individual's image and the software 
automatically extracts dozens of measurements (48).  These measurements include 
circumferences and lengths of certain specified regions that can be combined in order to 
asses a bulk body volume of the subject.  This volume can then be used for the purpose of 
body composition assessment. The scanner technology appears to be as reliable as other 
laboratory body composition assessment techniques.  
  The underestimation of BF via the scanner compared to DXA illustrates the need 
for a DXA based correction equation. A closer look at Figure 6 shows the 
underestimation to be fairly consistent across the population. If the underestimation was 
not consistent then the creation of a new prediction equation or correction factor would 
have been futile. The 3D MU equation was created in order to correct for this 
underestimation and when applied, (Figure 5) the difference between DXA and 3D MU is 
almost non-existent (0.2%).  A valid prediction equation will not only have similar 
means, it will have a high R
2
 and a low SEE (< 3.5%) when compared to the criterion 
(41). Particularly, the equation must have a low SEE. SEE is a measure of prediction 
error. The SEE is interpreted in the same way as the standard deviation.  Thus, the larger 
the spread of scores the larger the deviation or the larger the error. A low SEE will yield a 
more accurate predication equation with less variability. Determining the validity of these 
measures and assessing the accuracy of a new predication equation versus a criterion is 
essential for evaluating new methods of assessment.  Lohman has outlined the ability to 
accept new equations on the basis of SEE and criterion for new prediction equations (53). 
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The 3D MU has a SEE of 2.7% and thus meets Lohman’s criteria for a prediction 
equation.  
CONCLUSION 
The current study is the first to investigate the use of 3D body scanning 
technology for body composition assessment. Although the 3D body scanner shows 
promise as a method of evaluating BF, more work is needed before it can be considered 
an acceptable laboratory method of assessment. A 3D MU prediction equation was 
created that appears to be more accurate for young men than the current DoD equation. 
However, the 3D MU equation needs additional investigation and validation.  Scanning 
technology must more accurately measure head, hands, and feet before it will be as 
accurate as other laboratory methods. Future research should focus on different 
populations and in determining possibly sources of error.  
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EXTENDED LITERATURE REVIEW  
 
DEVELOPING A NEW METHOD OF BODY COMPOSITION ASSESSMENT 
USING PRINCIPLES OF DESITOMETRY 
DENSITOMETRY  
The term densitometry generally refers to the process of estimating body 
composition from body density.  The density of the human body (Db) is equivalent to a 
ratio of its mass (m) and volume (V).  Cadaver studies have shown lean tissue to be 
approximately 1.100 g/ml while fat tissue is ~0.090 g/ml (62).  Body mass is estimated 
from body weight, which is relatively easy to measure (55). Thus, in order to accurately 
measure body density and accurate volume must be obtained. Once both mass and 
volume are known equation A can be used (80): 
Db = m/ V.                        (A) 
The density of any material is a function of the proportions and densities of its 
components.  In the classic two-component (2C) model of body composition, body 
weight is divided into fat (F) and fat-free mass (FFM). Thus, the density can be found 
using equation B (80): 
1/ Db = F/ DF  + FFM/ DFFM           (B) 
The fat-free mass is a heterogeneous compartment that can be further separated 
into water (W), protein (P), and mineral (M) (16).  Thus, when combined with F a four-
compartment model of body composition can be derived in equation C (16, 80): 
1/ Db = F/ DF +W/ DW + P/ DP + M/ DM    (C) 
The assumptions of DF, P, W, and M are based upon limited data studies using 
animal and human cadavers by dissection and chemical analysis. 
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Assumptions. There are a several assumptions that are used when determining body 
fat from body density.  These assumptions can be used in order to increase or decrease 
the validity of the tests used in order to determine body density.  The assumptions are as 
follows (16, 54, 56, 86): 
1. Separate densities of compartments are additive.  Meaning that in a 2C model that 
body fat plus lean tissue will equal total weight. 
2. The densities of the compartments of the body are relatively constant from person 
to person. 
3. The proportions of the constituents other than fat are relatively constant. 
4. The person being measured differs from a standard reference body only in amount 
of body fat or adipose tissue. 
It is of note that in the 2C model the density of fat is assumed to be constant at 0.90 
g/ml and has been shown to be relatively constant even with site variation (29, 54).  
While this does hold true, the assumption that 0.90 g/ml for the average density of all 
body fat would have a relatively small error in the density formula with a possible 
exception to very lean subjects (54).  The two components of FFM, muscle and bone, 
have densities of 1.066 g/ml and 3.317 g/ml respectively (71).   
Differences in FFM are more critical to the assumptions made, variations have been 
found in several populations which allow for decreased validity of body fat estimation.  
These populations include and are not limited to (17, 22, 25, 54): Specialized trained 
groups, elderly, advanced maturation youth, gender, and racial differences.   Also, there 
is an inherent biological variability of FFM, assuming each source of variation is 
independent of each other, the total error using the law of propagation of errors is 
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estimated to be 3.9% or -0.0084 g/ml in DFFM in a general population and -0.0060 g/ml or 
2.8% in a specific population (86-87).  
 Body Density Equations.  Studies using healthy adults have been conducted in 
order to create equations which can convert density to %BF.  These equations can be 
used by any model which can provide body density.  The Brozek equation [%BF = 
{(4.57/Db)-4.141}x100] and the Siri equation [%BF = {(4.950/Db)-4.50}x100] are the 
most commonly used conversion equations (16, 86). While the two equations give similar 
results in healthy subjects they vary in specific populations.  The Brozek equation was 
based upon chemical composition of cadaver analysis and was intended to be used in 
young, healthy, non-athletic populations (15). The Siri equation was intended to be used 
in healthy adults and has been found to be more variable in subjects who were young, 
very lean, very obese, and those with high musculoskeletal development (71, 101).  Thus, 
when applying the two equations the specific population which is used should be of note 
and accounted for. 
Hydrodensitometry.  Hydrodensitometry can be separated into two approaches 
of determining body volume:  water displacement or underwater weighting.  Water 
displacement involves a person being directly immersed in water then measuring the 
amount of water displaced in a volumeter by the addition of the body (4). The amount of 
water displaced is equal to the volume of the subject.  An alternative to this method is 
underwater weighing, commonly referred to as hydrostatic weighing (HW).  HW  has 
often been considered the “gold standard” method of body composition assessment 
techniques (23).  HW uses Archimedes’s principle to determine total body volume and 
thus density by measuring the difference between a subject’s weight in water and that in 
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air (12).   A study conducted by Ward et al. showed good re-test reliability in the two 
methods (r = 0.96 for water displacement and r = 0.99 for HW) and good agreement 
between method (r = 0.96) with the mean difference in %BF between methods being 
0.7% (94).  HW is considered to be the original and most acceptable 2C. In lay terms, 
since fat is less dense than water, it floats, while lean body tissue (muscle and bone) is 
denser than water, and thus sinks.   
While HW is an acceptable laboratory method, it has several methodological 
issues, including: subject position, determining residual volume, number of trials, 
comfort level in water, and head placement (14, 26, 77, 90, 99-100). While density can be 
estimated with acceptable precision and accuracy in most populations, the assumption of 
an invariant fat-free composition, commonly used to convert density to composition, may 
not be valid for some individuals.  The total theoretical error of HW is estimated to be 
0.0062 g/ml or ~2% body fat (56).  This error combines the error of FFM (as previously 
discussed) and the technical error using HW.  It should be noted that this is representative 
of a specific population and would have higher error in a general population.  
Accuracy of Hydrostatic Weighing.  Sources of variation in body density are 
due to three biological sources: fat, water and/or mineral content.  Due to variations in the 
water and mineral content of FFM the interpretation can lead to errors of 2-4% depending 
on the population (53).  There are several sources of variation in body density 
measurement.  Variation in residual lung volume is considered to be the largest (3).  The 
combined error from residual volume is estimated to be 0.00139 g/ml (99-100).  
Variations due to bodyweight, underwater weighing and the measurement of water 
temperature at the time of measurements are much smaller than residual volume and have 
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a combined error of 0.0006g/ml (100).  Variations in body density of the combined is 
about 0.0015-0.0020 g/ml and is considered to be the characteristic trail-to-trail variation 
within a given day using most hydrostatic weighing systems.  Within-subjects standard 
deviation larger than 0.0020 g/ml reflect larger measurement errors in one or more of the 
components of body density and indicate a need to improve the measurement precision 
(53). 
Bod Pod.  Air displacement plethysmograph uses the relationship between 
pressure and volume to derive body volume.  In this method body volume is equal to the 
volume of air remaining in the chamber after the subject has been placed into it.  
Although  the respiration movement, gas and water vapor exchange, and heat generated 
by the body in a closed space can make a significant impact on the accuracy of the 
measurement (23).  
The Bod Pod appears to have overcome some of these challenges in order to make 
an accurate measurement of body volume.  The Bod Pod is a 2C model that determines 
body volume by measuring the amount of air displaced by the body (7, 21, 31).  Body 
density can then  be determined when weight is taken and thus BF can be determined 
using the Siri equation (86). The Bod Pod is widely used in laboratories due to its ease of 
use, speed, and portability.  The Bod Pod tends to accurately measure BF compared to 
other laboratory methods (8, 13, 61).  Dempster and Aitkens have described the 
procedure and principles in more detail (23).  Briefly, the Bod Pod consists of a single 
fiberglass structure with two internal chambers separated by an oscillating diaphragm 
which allows for small volume changes in the two chambers.  The volume changes are 
exactly equal in magnitude but opposite in sign, these shifts result in complementary 
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pressure fluctuation in the two chambers.  The relationship between pressure and volume 
is calculated using Poisson’s Law: 
Poisson’s Law:    P1/P2 = (V2/V1)γ 
Where P1 and V1 represent one paired pressure and volume, P2 and V2 represent 
a second and γ is the ration of the specific heat of the gas at a constant pressure to that at 
a constant volume (92).  When this method is applied to inanimate objects the validity 
and reliability are excellent (r = 1.0, SEE 0.004 L) (23).  When applied to humans and 
compared with HW on same-day tests the Bod Pod was slightly better than HW with 
average coefficients of variation of 1.7% for Bod Pod and 2.3% for HW (68).  The mean 
difference between the two methods was only 0.3% (r = 0.96, SEE 1.81%). Mean 
differences
 
between in BF measured by the BOD POD and DXA have varied. The
 
differences in BF  have ranged from the  negative (range: -2.0% to -3.0%) in four  studies 
(20, 52, 70, 83) and positive (1.7 %BF) in one of
 
the studies (93) . 
Dual energy radiography. Duel energy radiography is a method of assessing 
tissue densities and content of a body by using X-ray rather than gamma-ray radiation to 
measure whole body and regional compositions (35, 64-65).  Under this category of 
technologies is duel energy X-ray absortometry (DXA) which allows for a 3C model that 
measures bone mineral density (BMD), lean body mass, and fat mass.  DXA has been 
shown to be an effective, easy, and safe method of assessing body composition across 
populations (8).  Although DXA uses radiation, the dosage is very low (<5 mrem) (9) and 
therefore many researchers refer to it as the new “practical gold standard” of body 
composition assessment (3, 4).   DXA is precise over repeated measurements on subjects 
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in lean tissue and BMD.  Coefficients of variations from BMD have been reported to be 
0.6% and 1.6% in soft tissues, such as fat and lean, which were similar to that of 
established 2C models (45, 63).  DXA is not without assumptions and limitations, 
variations in fat distribution, body thickness and fat content of bone marrow are sources 
of biological variation (53).  Though these variations can be minimal and with better 
technology and software these variation are minimal. Samples in postmenopausal women 
have shown an error of 0.0026g/ml or 1.2%BF (45).  Recent studies have shown DXA to 
be precise and reproducible in measuring BMD, lean tissue, and fat mass in children (51).  
Also, the use of DXA has been expanded to be used in rodent models with excellent 
precision, R
2
=0.98, in measuring of FFM (89).  
Three-dimensional body scanning.  The 3D body scanner was originally 
developed to be used in the fashion industry for improved fitting of clothes. Body 
scanners use light to illuminate an objects, or in this case the human body, while a series 
of cameras capture reflected light resulting in a detailed digital 3D image.  The scanner 
allows for linear, two- dimensional and three-dimensional measurements of the body’s 
surface.  The body measurements are very precise and are much more accurate than 
typical anthropometric measurements determined by tape measures, sliding calipers, and 
other devices (33).  More importantly, since the scanner measures total body volume, BF 
can easily be predicted by calculating body density. The scanner is thus a 2C model that 
might have promise as another method of BF assessment. The scanning procedure is very 
fast (5 seconds) and completely non-invasive which allows for mass testing.  
 No one has yet compared 3D scanner produced body density to DXA or any 
other laboratory method.  Previous studies by the United States Department of Defense 
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(DoD) have looked at using 3D body scanning as a novel, effective method of assessing 
body composition (33). However, instead of using body volume to calculate density and 
thus fatness, they used circumferences to predict BF.  This study was not published.  
Comparing BF of 37 white males attained from DXA and 3D body scanning, linear 
regression analysis from circumferences revealed moderate and statistical significance 
(p<0.05) and Pearson correlation coefficients with moderate standard errors (R
2
=0.74, 
SEE= 3.3).  Generally, using circumferences as a measure of BF is considered to be a 
crude measure with much variability (27, 41, 55).   
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CONSENT FORM TO PARTICIPATE IN A RESEARCH STUDY 
 
INVESTIGATOR’S NAME:  JUSTIN RYDER, BA.    
PROJECT # 1129817 
DATE OF PROJECT APPROVAL:  FEBRUARY 25, 2009 
 
FOR HS IRB USE ONLY 
APPROVED  
 
 
________________________________________________ 
HS IRB Authorized Representative                          Date 
 
EXPIRATION DATE:   __________________________ 
 
 
 
STUDY TITLE: THREE DIMENSIONAL BODY SCANNING AS A NEW 
TECHNIQUE FOR MEASURING BODY COMPOSITION. 
 
INTRODUCTION 
This consent may contain words that you do not understand.  Please ask the 
investigator or the study staff to explain any words or information that you do not 
clearly understand. 
 
This is a research study that includes only people who choose to participate.  As a study 
participant you have the right to know about the procedures that will be used in this 
research study so that you can make the decision whether or not to participate.  The 
information presented here is simply an effort to make you better informed so that you 
may give or withhold your consent to participate in this research study.   
 
Please take your time to make your decision and discuss it with your family and friends. 
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You are being asked to take part in this study because you are a male between the ages of 18 
and 55. 
 
This study requires no funding and will be presented to the subjects free of charge. 
 
In order to participate in this study, it will be necessary to give your written consent. 
 
 
WHY IS THIS STUDY BEING DONE? 
The purpose of this study is to determine if the 3D body scanner is an effective method of 
measuring body composition in comparison with known techniques. 
 
 This study is a pilot study to be under taken in order to see what the applicability of the 3D 
body scanner is to body composition.  It is hypothesized that it can be used as a non-invasive 
tool for measuring body composition. 
 
HOW MANY PEOPLE WILL TAKE PART IN THE STUDY? 
About 200 people will take part in this study at the University of Missouri-Columbia. 
 
WHAT IS INVOLVED IN THE STUDY? 
If you choose to participate in this study, you will complete the following items: 1) one duel x-
ray absorbtometry scan (DXA), 2) one Bod Pod evaluation, 3) one skinfold examination, 4) one 
bio-electrical impendence (BIA) assessment, 5) body pictures, and 6) one 3D body scan 7) Hand 
and foot volume assessment via water displacement. 
 
If you take part in the study, you will have the following test and procedures: 
1) You will have body weight, height, skinfolds, BMI, and waist-to-hip ratio measurements 
taken. 
2) You will have a body composition test measured by the DXA.  This will require you laying flat 
on a bed as still as possible for about two minutes.  You will be wearing no shoes, no metal, 
t-shirt and gym shorts.  The DXA uses X-rays to determine your body composition and is 
considered the gold standard. 
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3) You will have a body composition test measure by the Bod Pod.  This will require you to sit 
inside an “egg-shaped” chamber for 5 minutes while breathing normally.  You will be 
wearing only a swimming suit and swim cap (which will be provided). 
4) You will have your picture taken while in your swimming suit.  These pictures will be used to 
illustrate different body types and body fat percentages for publication.  If used your face 
will be blurred to protect your identity.  
5) You will have skinfolds taken.  These measurements require a caliper device which pinches 
your skin and subcutaneous fat (fat just below your skin).  This can cause discomfort, 
redness and bruising. 
6) You will have a bio-electrical impedance (BIA) test performed.  This sends an electrical current 
through your body but you will not feel it.   
7) You will have a 3D body scan of your body while wearing non-tight underwear only.  The body 
scan is a non-invasive procedure which takes about ten seconds. 
8) Hand and foot volume will be measured by water displacement using a volumeter. The 
volumeter will be used in order to ascertain proper foot volume in order to add accuracy to 
the body scanner measurements.  A persons hand/ foot can be placed in it and the amount 
of water spill over (displaced) will be measured in order to get an accurate foot volume. 
9) You will be asked to sign this consent form before beginning the study. 
 
 
HOW LONG WILL I BE IN THE STUDY? 
We think you will be in the study for 2 hours in one day.  The investigator and/or your doctor 
may decide to take you off this study if you become uncomfortable with the several tests you 
have to perform. 
 
You can stop participating at any time.  Your decision to withdraw from the study 
will not affect in any way your medical care and/or benefits.  If you decide to stop 
participating in the study, you are encouraged to discuss your decision with Mr. 
Justin Ryder. 
 
 
WHAT ARE THE RISKS OF THE STUDY? 
You will be exposed to small amounts of radiation during the DXA scan.  Radiation effects are 
cumulative. 
 
Reproductive risks: The effects of the DXA scan on the male reproductive system are unknown 
and could cause harm.  If you have questions about the reproductive issues, please discuss them 
with your investigator or your doctor. 
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There is a risk of bruising during the skinfold test. Calipers are used to pinch the skin which can 
cause discomfort and in some cases bruising.  Some subjects may experience claustrophobia 
when using the Bod Pod test.   
 
For the reasons stated above the investigator will observe you closely while giving the treatment 
described and, if you have any worrisome symptoms or symptoms that the investigator or his 
associates have described to you, notify the investigator immediately.  Mr. Justin Ryder’s telephone 
number is 314-882-6838 or Dr. Steve Ball can be reached at 573-882-2334.  For more information 
about risks and side effects please e-mail Mr. Justin Ryder at jrrgy5@mizzou.edu or Dr. Steve 
Ball at ballsd@missouri.edu. 
 
 
ARE THERE BENEFITS TO TAKING PART IN THE STUDY? 
If you agree to take part in this study, there may or may not be direct medical benefit to you. 
You may expect to benefit from taking part in this research to the extent that you are 
contributing to medical knowledge.  We hope the information learned from this study will 
benefit the methodology of calculating body composition in the future. Also it will enable 
participants to learn about their body composition. 
 
There is no guarantee that taking part in this research will result in any improvement in current 
methods of measuring body composition.  
 
WHAT OTHER OPTIONS ARE THERE? 
 
An alternative is to not participate in this research study. 
 
Please discuss these and other options with Mr. Justin Ryder and/or Dr. Steve Ball. 
 
WHAT ABOUT CONFIDENTIALITY? 
Information produced by this study will be stored in the investigator’s file and identified 
by a code number only.  The code key connecting your name to specific information 
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about you will be kept in a separate, secure location.  Information contained in your 
records may not be given to anyone unaffiliated with the study in a form that could 
identify you without your written consent, except as required by law.  If the investigator 
conducting this study is not your primary, or regular doctor, Mr. Justin Ryder must obtain 
your permission before contacting your regular doctor for information about your past 
medical history or to inform them that you are in this trial. 
 
It is possible that your medical and/or research record, including sensitive information and/or 
identifying information, may be inspected and/or copied by the study sponsor (and/or its 
agent), the Food and Drug Administration (FDA), federal or state government agencies, or 
hospital accrediting agencies, in the course of carrying out their duties.  If your record is 
inspected or copied by the study sponsor (and/or its agents), or by any of these agencies, the 
University of Missouri-Columbia will use reasonable efforts to protect your privacy and the 
confidentiality of your medical information. 
 
The results of this study may be published in a medical book or journal or used for 
teaching purposes.  However, your name or other identifying information will not be used 
in any publication or teaching materials without your specific permission.   
 
In addition, if photographs, audiotapes or videotapes were taken during the study that 
could identify you, then you must give special written permission for their use.  In that 
case, you will be given the opportunity to view or listen, as applicable, to the 
photographs, audiotapes or videotapes before you give your permission for their use if 
you so request. 
 
WHAT ARE THE COSTS? 
There is no cost to you for any of the body composition assessments.  However, you will be 
paying for the normal cost your swimsuit, gym shorts and t-shirt.  If you already have these 
items then you have no cost associated for this study.   
 
 
WILL I BE PAID FOR PARTICIPATING IN THE STUDY? 
You will receive no payment for taking part in this study. 
 
WHAT IF I AM INJURED? 
It is not the policy of the University of Missouri to compensate human subjects in the event 
the research results in injury.  The University of Missouri, in fulfilling its public 
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responsibility, has provided medical, professional and general liability insurance coverage 
for any injury in the event such injury is caused by the negligence of the University of 
Missouri, its faculty and staff.  The University of Missouri also will provide, within the 
limitations of the laws of the State of Missouri, facilities and medical attention to subjects 
who suffer injuries while participating in the research projects of the University of Missouri.  
In the event you have suffered injury as the result of participation in this research program, 
you are to contact the Risk Management Officer, telephone number (573) 882-1181, at the 
Health Sciences Center, who can review the matter and provide further information.  This 
statement is not to be construed as an admission of liability. 
 
WHAT ARE MY RIGHTS AS A PARTICIPANT? 
Participation in this study is voluntary.  You do not have to participate in this study.  Your 
present or future care will not be affected should you choose not to participate.  If you decide 
to participate, you can change your mind and drop out of the study at any time without 
affecting your present or future care in the University of Missouri.  Leaving the study will not 
result in any penalty or loss of benefits to which you are entitled.  In addition, the investigator of 
this study may decide to end your participation in this study at any time after Mr. Justin Ryder or 
Dr. Steve Ball has explained the reasons.   
 
You will be informed of any significant new findings discovered during the course of this study 
that might influence your health, welfare, or willingness to continue participation in this study.  
 
 
WHOM DO I CALL IF I HAVE QUESTIONS OR PROBLEMS? 
If you have any questions regarding your rights as a participant in this research and/or concerns 
about the study, or if you feel under any pressure to enroll or to continue to participate in this 
study, you may contact the University of Missouri Health Sciences Institutional Review Board 
(which is a group of people who review the research studies to protect participants’ rights) at 
(573) 882-3181.   
 
You may ask more questions about the study at any time.  For questions about the study or 
research related injury, please contact Mr. Justin Ryder via e-mail at jrrgy5@mizzou.edu or Dr. 
Ball at ballsd@missouri.edu. 
 
A copy of this consent form will be given to you to keep. 
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SIGNATURE 
 
I confirm that the purpose of the research, the study procedures, the possible risks and 
discomforts as well as potential benefits that I may experience have been explained to me.  
Alternatives to my participation in the study also have been discussed.  I have read this consent 
form and my questions have been answered.  My signature below indicates my willingness to 
participate in this study. 
 
 
            
   
Subject/Patient*        Date 
 
 
            
   
Legal Guardian/Advocate/Witness (if required)**    Date 
 
 
            
   
Additional Signature (if required) (identify relationship to subject)*** Date 
 
*A minor’s signature on this line indicates his/her assent to participate in this study.  A minor’s 
signature is not required if he/she is under 7 years old.  Use the “Legal 
Guardian/Advocate/Witness” line for the parent’s signature, and you may use the "Additional 
Signature" line for the second parent’s signature, if required. 
 
**The presence and signature of an impartial witness is required during the entire informed 
consent discussion if the patient or patient’s legally authorized representative is unable to read.   
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***The "Additional Signature" line may be used for the second parent’s signature, if required.  
This line may also be used for any other signature which is required as per federal, state, local, 
sponsor and/or any other entity requirements. 
 
“If required” means that the signature line is signed only if it is required as per federal, state, 
local, sponsor and/or any other entity requirements. 
 
 
SIGNATURE OF STUDY REPRESENTATIVE 
I have explained the purpose of the research, the study procedures, identifying those that 
are investigational, the possible risks and discomforts as well as potential benefits and 
have answered questions regarding the study to the best of my ability. 
 
 
            
   
Study Representative****      Date 
 
****Study Representative is a person authorized to obtain consent.  Per the policies of the 
University of Missouri Health Care, for any 'significant risk/treatment' study, the Study 
Representative must be a physician who is either the Principal or Co-Investigator.  If the study is 
deemed either 'significant risk/non-treatment' or 'minimal risk,' the Study Representative may 
be a non-physician study investigator.   
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DATA COLLECTION SHEET 
 
 
  
71 
 
JUSTIN RYDER THESIS STUDY 
SUBJECTS NUMBER:________________________ 
BIRTH DATE:__________________________ 
AGE:________(YR) 
WEIGHT:______________(LB) 
HEIGHT:_______________(IN) 
 (cm)  TRIAL 1  TRIAL 2 TRIAL 3 MEAN 
WAIST:                      ________        ________        _______          _______ 
HIP:                            ________        ________        _______          _______ 
________________________________________________________________________ 
BIA 
Z =   Ph =   R =   Xc= 
________________________________________________________________________ 
DXA %BF RESULT =  
________________________________________________________________________                                                                                                                                                  
SKINFOLDS 
CHEST:                      ________        ________        _______          _______ 
SUBSCAPULAR:      ________        ________        _______          _______ 
MIDAXILLARY:      ________        ________        _______          _______ 
TRICEP:                     ________        ________        _______          _______ 
ABDOMEN:               ________        ________        _______          _______ 
SUPRAILIAC:           ________        ________        _______          _______ 
THIGH:                      ________        ________        _______          _______ 
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FOOT VOLUME 
RIGHT =  
LEFT= 
HAND VOLUME 
RIGHT = 
LEFT = 
HEAD MEASURES 
HEAD CIRCUMFRENCE= 
HEAD LENGTH =  
HAND MEASURES 
FIRGURE OF 8 RIGHT =  
FIGURE OF 8 LEFT = 
 
________________________________________________________________________ 
3D BODY SCANNER  
BULK VOLUME= 
WAIST= 
HIP= 
ABDOMEN= 
DoD FITNESS EQUATION = 
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APPENDIX D: 
ADDITIONAL STATISTICAL RESULTS 
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Manually measured volumes of head, hand, and feet.
Mean + SD Range
Head (L) 4.32 ± 0.49 2.11 - 6.74
Right Hand (L) 0.42 ± 0.11 0.26 - 0.76
Left Hand (L) 0.42 ± 0.11 0.22 - 0.74
Right Foot (L) 0.96 ± 0.14 0.68 - 1.49
Left Foot (L) 0.95 ± 0.13 0.68 - 1.50
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Correlation of all variable to DXA
n = 85 Age Height (M) Weight scale(kg)
Age 1 0.109 .258**
Height (M) 1 .462**
Weight scale(kg) 1
Weight Bod Pod (lb)
Waist by hand (cm)
Hip by hand (cm)
BMI
WHR
SiriSCAN
Bod Pod BF Siri
DoD equation
Hip by Scanner (cm)
Waist by Scanner (cm)
Abdomen by Scanner (cm)
DXA
* p < 0.05     ** p <0.01  
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Correlation of all variable to DXA
n = 85 Age Height (M) Weight scale(kg)
Age 1 0.109 .258**
Height (M) 1 .462**
Weight scale(kg) 1
Weight Bod Pod (lb)
Waist by hand (cm)
Hip by hand (cm)
BMI
WHR
SiriSCAN
Bod Pod BF Siri
DoD equation
Hip by Scanner (cm)
Waist by Scanner (cm)
Abdomen by Scanner (cm)
DXA
* p < 0.05     ** p <0.01  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
77 
 
n = 85 Weight Bod Pod (lb) Waist by hand (cm) Hip by hand (cm)
Age .243* .310** 0.164
Height (M) .467** 0.177 .243*
Weight scale(kg) 1.000** .813** .868**
Weight Bod Pod (lb) 1 .807** .870**
Waist by hand (cm) 1 .731**
Hip by hand (cm) 1
BMI
WHR
SiriSCAN
Bod Pod BF Siri
DoD equation
Hip by Scanner (cm)
Waist by Scanner (cm)
Abdomen by Scanner (cm)
DXA
* p < 0.05     ** p <0.01  
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n = 85 BMI WHR SiriSCAN Bod Pod BF Siri
Age .231* .313** 0.038 .297**
Height (M) -0.149 0.062 -0.131 0.020
Weight scale(kg) .806** .387** 0.042 .600**
Weight Bod Pod (lb) .799** .368** 0.040 .596**
Waist by hand (cm) .798** .775** 0.104 .690**
Hip by hand (cm) .795** 0.141 0.130 .660**
BMI 1 .412** 0.138 .673**
WHR 1 0.034 .371**
SiriSCAN 1 0.160
Bod Pod BF Siri 1
DoD equation
Hip by Scanner (cm)
Waist by Scanner (cm)
Abdomen by Scanner (cm)
DXA
* p < 0.05     ** p <0.01  
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n = 85 DoD equation Hip by Scanner (cm) Waist by Scanner (cm)
Age .226* .212* .302**
Height (M) 0.079 .210* .195*
Weight scale(kg) .623** .897** .851**
Weight Bod Pod (lb) .624** .893** .852**
Waist by hand (cm) .723** .788** .854**
Hip by hand (cm) .558** .894** .798**
BMI .663** .859** .830**
WHR .510** .320** .497**
SiriSCAN 0.167 0.145 0.120
Bod Pod BF Siri .623** .683** .748**
DoD equation 1 .628** .802**
Hip by Scanner (cm) 1 .848**
Waist by Scanner (cm) 1
Abdomen by Scanner (cm)
DXA
* p < 0.05     ** p <0.01  
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n = 85 Abdomen by Scanner (cm) DXA
Age .394** .271**
Height (M) .249* -0.043
Weight scale(kg) .791** .514**
Weight Bod Pod (lb) .791** .517**
Waist by hand (cm) .737** .556**
Hip by hand (cm) .777** .597**
BMI .724** .617**
WHR .348** .233*
SiriSCAN 0.119 .237*
Bod Pod BF Siri .719** .856**
DoD equation .680** .629**
Hip by Scanner (cm) .815** .656**
Waist by Scanner (cm) .856** .751**
Abdomen by Scanner (cm) 1 .742**
DXA 1
* p < 0.05     ** p <0.01  
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APPENDIX E: 
RAW DATA 
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Subject Age Height(in) Weight(lb) BodPodWeight (lb) Bodpod BF Bulk vol scan DXA BF R hand vol
1.00 22.00 70.75 193.00 191.90 7.10 2.77 9.80 450.00
2.00 22.00 70.25 194.00 192.90 10.60 2.80 14.30 450.00
3.00 22.00 72.25 187.50 185.90 12.60 2.80 18.80 400.00
4.00 23.00 68.75 156.00 2.23 8.10 390.00
5.00 22.00 74.25 197.00 196.10 16.90 2.93 21.10 455.00
6.00 22.00 67.25 181.00 179.40 10.50 2.68 14.60 350.00
7.00 20.00 72.25 236.00 235.40 23.40 3.46 21.20 405.00
8.00 22.00 72.00 167.50 166.20 9.60 2.48 11.30 315.00
9.00 21.00 71.25 166.00 165.40 7.30 2.41 10.50 385.00
10.00 21.00 68.50 182.50 181.50 19.50 2.69 21.80 445.00
11.00 22.00 69.50 279.50 279.10 37.30 4.20 31.90 535.00
12.00 21.00 68.00 179.00 178.80 16.80 2.71 21.40 420.00
13.00 19.00 70.00 161.00 160.30 1.40 2.32 8.20 430.00
14.00 21.00 72.00 197.00 196.00 11.60 2.89 16.50 410.00
15.00 21.00 70.75 173.50 171.30 21.20 2.58 21.50 355.00
16.00 18.00 67.00 123.50 122.70 1.30 1.78 16.60 310.00
17.00 21.00 76.00 234.00 232.60 18.30 3.50 21.40 550.00
18.00 22.00 72.50 194.00 192.30 12.90 2.88 21.80 430.00
19.00 23.00 68.50 182.00 180.80 19.10 2.67 19.70 400.00
20.00 20.00 70.25 141.00 142.80 5.50 2.89 12.60 360.00
21.00 21.00 69.25 195.00 194.00 17.70 2.04 21.10 460.00
22.00 23.00 66.75 168.50 165.80 17.50 2.44 18.30 355.00
23.00 20.00 72.00 183.50 180.00 19.10 2.65 17.60 375.00
24.00 23.00 69.00 159.00 157.20 8.90 2.28 19.10 400.00
25.00 20.00 73.00 149.00 148.40 9.80 2.17 13.70 405.00
26.00 22.00 71.00 162.00 160.80 8.50 2.35 18.30 475.00
27.00 19.00 64.50 152.00 152.10 14.10 2.32 15.10 325.00
28.00 21.00 77.00 265.00 263.60 14.40 3.88 14.90 630.00
29.00 22.00 71.00 189.00 187.60 14.50 2.79 15.40 400.00
30.00 21.00 71.50 154.00 153.60 8.10 2.25 12.70 430.00
31.00 19.00 68.00 164.00 162.10 18.60 2.85 16.20 520.00
32.00 22.00 71.00 195.00 192.70 16.00 2.35 16.90 470.00
33.00 21.00 68.50 174.00 173.50 11.40 2.59 15.30 505.00
34.00 21.00 71.75 179.00 178.10 11.50 2.69 12.20 550.00
35.00 25.00 73.50 155.00 2.26 9.60 435.00
36.00 21.00 69.50 198.00 197.40 21.90 3.00 26.10 420.00
37.00 20.00 66.50 190.00 189.30 9.40 2.77 14.70 410.00
38.00 20.00 73.50 181.00 180.30 12.40 2.66 15.10 510.00
39.00 20.00 68.00 164.00 163.70 12.60 2.42 14.80 400.00
40.00 20.00 68.50 165.00 164.20 8.40 2.44 13.70 385.00
41.00 21.00 71.00 167.00 165.80 10.00 2.39 13.10 435.00
42.00 21.00 69.00 167.00 166.50 12.20 2.46 13.90 370.00
43.00 21.00 70.00 180.00 178.90 11.10 2.62 15.50 525.00
44.00 21.00 76.50 195.00 194.50 4.20 2.87 12.90 525.00
45.00 19.00 74.00 193.00 191.80 8.30 2.81 14.00 535.00
46.00 21.00 67.50 173.00 172.60 10.20 2.81 15.80 410.00
47.00 23.00 69.50 178.00 176.90 12.80 2.58 15.60 470.00
48.00 21.00 55.50 129.50 128.70 5.50 2.68 15.50 280.00
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Subject Age Height(in) Weight(lb) BodPodWeight (lb) Bodpod BF Bulk vol scan DXA BF R hand vol
49.00 19.00 72.50 176.00 175.50 1.80 1.89 9.30 395.00
50.00 19.00 72.50 162.00 160.90 6.90 2.56 15.70 405.00
51.00 24.00 71.75 173.50 172.50 11.60 2.36 19.30 445.00
52.00 25.00 69.50 179.50 177.20 10.00 2.57 13.70 395.00
53.00 20.00 72.50 178.00 177.20 11.70 2.60 12.60 415.00
54.00 21.00 69.80 163.40 162.80 5.60 2.65 10.50 365.00
55.00 19.00 73.25 259.00 258.20 22.70 2.39 22.90 560.00
56.00 21.00 71.00 172.50 171.90 9.20 3.89 12.90 425.00
57.00 21.00 67.75 160.50 157.20 6.00 2.53 13.40 500.00
58.00 18.00 68.50 158.00 159.70 3.20 2.32 11.80 375.00
59.00 21.00 68.00 165.00 164.30 5.80 2.31 11.80 385.00
60.00 20.00 69.00 154.00 153.30 14.60 2.43 15.60 320.00
62.00 21.00 69.75 150.50 149.80 8.10 2.20 13.70 360.00
63.00 19.00 69.50 153.00 152.50 6.00 2.23 10.40 375.00
64.00 21.00 70.50 168.00 167.00 13.00 2.46 16.00 425.00
65.00 26.00 74.50 221.00 220.40 7.90 3.32 16.20 485.00
66.00 19.00 71.00 171.50 170.80 3.70 2.44 12.00 450.00
67.00 25.00 66.50 167.50 166.60 25.90 2.46 25.00 300.00
68.00 24.00 69.50 155.00 154.30 8.00 2.30 16.40 305.00
69.00 22.00 70.75 230.00 228.90 29.20 3.51 29.40 370.00
70.00 21.00 72.25 146.00 145.60 7.80 2.18 13.50 260.00
71.00 20.00 71.00 176.00 175.40 11.10 2.57 14.20 265.00
72.00 20.00 68.50 147.50 145.30 5.60 2.14 12.60 255.00
73.00 23.00 69.50 214.50 212.30 37.60 3.22 32.80 320.00
74.00 22.00 72.00 152.00 150.20 13.70 2.23 13.90 365.00
75.00 21.00 69.50 162.00 161.00 8.40 2.34 11.30 310.00
76.00 19.00 71.00 177.00 176.20 10.50 2.64 16.40 410.00
77.00 30.00 67.25 197.50 196.90 19.80 2.97 450.00
78.00 27.00 74.75 202.00 201.50 12.10 2.96 15.40 470.00
79.00 24.00 67.75 168.50 167.90 27.30 2.48 25.30 330.00
80.00 25.00 67.00 162.50 162.00 12.70 2.33 12.40 355.00
81.00 24.00 71.50 222.00 221.00 22.50 3.33 21.80 510.00
82.00 23.00 73.00 180.00 179.50 2.20 2.65 12.20 440.00
83.00 21.00 73.50 197.50 196.70 13.00 2.93 18.10 410.00
84.00 21.00 64.50 148.00 147.60 1.50 2.23 18.60 295.00
85.00 22.00 71.00 158.00 157.10 4.90 2.37 17.60 395.00
86.00 22.00 66.50 156.00 155.00 9.00 2.25 13.20 375.00
87.00 28.00 72.25 203.00 202.00 21.80 3.05 21.80 385.00
88.00 22.00 70.00 186.50 185.70 9.70 2.76 16.00 455.00
89.00 20.00 68.50 176.00 175.20 21.10 2.60 18.80 345.00
90.00 27.00 75.25 157.00 157.00 10.80 2.39 14.60 360.00
91.00 22.00 69.25 162.00 161.10 9.00 2.39 17.50 375.00
92.00 23.00 72.00 165.50 165.00 5.80 2.40 11.70 395.00
93.00 30.00 73.00 191.00 190.00 13.40 2.84 18.70 360.00
94.00 20.00 72.00 157.50 157.00 4.00 2.30 11.70 320.00
95.00 22.00 69.75 173.00 172.00 14.70 2.54 16.80 405.00
96.00 21.00 72.75 182.00 180.10 3.90 2.65 12.60 405.00
97.00 24.00 70.50 220.00 3.24 16.80 325.00
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Subject L hand vol R foot vol L foot vol Head Length Head Circ Head vol Waist hand hip hand WHR BMI
1.00 443.00 1065.00 1043.00 19.20 57.10 4446.35 86.00 100.50 0.86 27.17
2.00 460.00 925.00 930.00 19.60 57.70 4527.70 86.00 102.00 0.84 27.70
3.00 400.00 860.00 930.00 20.40 60.50 5037.26 84.00 101.50 0.83 25.31
4.00 395.00 1085.00 1055.00 20.80 56.00 4012.93 77.30 97.40 0.79 23.25
5.00 475.00 1250.00 1175.00 20.40 59.60 4842.14 85.80 104.40 0.82 25.18
6.00 350.00 900.00 865.00 20.40 59.60 4842.14 85.20 101.70 0.84 28.20
7.00 410.00 1015.00 1020.00 19.70 58.00 4580.55 98.50 113.70 0.87 31.85
8.00 370.00 880.00 830.00 19.20 57.10 4446.35 86.70 92.40 0.94 22.76
9.00 375.00 995.00 1025.00 19.30 54.50 3870.49 77.70 97.80 0.79 23.04
10.00 435.00 995.00 965.00 19.00 57.00 4449.04 93.00 101.70 0.91 27.40
11.00 535.00 1155.00 1190.00 20.40 61.40 5232.38 122.30 120.80 1.01 40.77
12.00 430.00 990.00 940.00 18.60 56.30 4346.02 86.30 104.40 0.83 27.27
13.00 460.00 915.00 910.00 19.30 58.10 4650.97 76.60 90.20 0.85 23.15
14.00 410.00 965.00 945.00 19.90 57.70 4491.14 82.50 106.40 0.78 26.77
15.00 380.00 1000.00 990.00 19.60 57.70 4527.70 84.40 102.20 0.83 24.42
16.00 315.00 805.00 810.00 19.60 56.00 4159.14 64.40 89.60 0.72 19.38
17.00 560.00 1210.00 1170.00 19.00 57.00 4449.04 94.50 108.30 0.87 28.54
18.00 415.00 975.00 930.00 20.40 58.70 4647.02 63.80 107.00 0.60 26.00
19.00 395.00 890.00 880.00 19.30 57.80 4585.93 84.60 103.20 0.82 27.33
20.00 390.00 910.00 855.00 19.50 54.60 3867.80 70.00 92.00 0.76 20.13
21.00 465.00 1040.00 1010.00 19.30 56.30 4260.73 88.00 104.80 0.84 28.65
22.00 340.00 830.00 855.00 19.60 56.20 4202.50 82.00 97.00 0.85 26.64
23.00 375.00 1055.00 1030.00 20.40 58.30 4560.30 86.00 94.50 0.91 24.94
24.00 400.00 870.00 850.00 19.50 60.10 5060.20 78.00 94.90 0.82 23.53
25.00 385.00 945.00 955.00 19.40 55.50 4075.10 68.40 87.50 0.78 19.70
26.00 430.00 1070.00 1070.00 19.00 56.20 4275.60 76.10 95.50 0.80 22.64
27.00 310.00 850.00 830.00 19.80 56.70 4286.53 77.10 97.10 0.79 25.74
28.00 585.00 1485.00 1500.00 20.20 58.00 4519.63 91.50 118.00 0.78 31.49
29.00 415.00 1015.00 1000.00 19.50 57.70 4539.88 94.50 102.00 0.93 26.42
30.00 405.00 950.00 885.00 19.10 56.30 4285.10 73.50 93.10 0.79 21.22
31.00 465.00 1075.00 1070.00 20.50 57.50 4374.68 84.50 95.00 0.89 24.99
32.00 485.00 1025.00 925.00 19.50 56.00 4171.32 88.00 104.00 0.85 27.25
33.00 490.00 1080.00 995.00 19.00 58.00 4665.84 87.00 101.00 0.86 26.13
34.00 580.00 1210.00 1180.00 20.50 59.00 4699.88 78.50 102.00 0.77 24.50
35.00 455.00 925.00 875.00 19.50 56.00 4171.32 71.00 89.00 0.80 20.21
36.00 425.00 1095.00 1055.00 18.60 55.00 4064.18 90.80 105.30 0.86 28.88
37.00 425.00 900.00 955.00 18.80 56.20 4299.97 85.80 97.60 0.88 30.27
38.00 510.00 1105.00 1105.00 19.40 47.30 2297.34 78.80 98.40 0.80 23.61
39.00 400.00 1090.00 1090.00 19.70 54.50 3821.75 77.70 94.40 0.82 24.99
40.00 385.00 825.00 825.00 19.30 46.40 2114.41 79.60 97.00 0.82 24.77
41.00 405.00 940.00 960.00 20.00 56.80 4283.84 82.10 96.20 0.85 23.34
42.00 345.00 970.00 895.00 20.60 58.00 4470.90 80.20 98.30 0.82 24.71
43.00 475.00 1200.00 1110.00 20.30 58.50 4615.85 81.00 101.00 0.80 25.88
44.00 535.00 1065.00 1045.00 23.50 59.80 4507.80 83.50 101.00 0.83 23.48
45.00 550.00 1200.00 1200.00 20.30 59.00 4724.25 81.50 103.00 0.79 24.83
46.00 410.00 885.00 925.00 18.50 56.50 4401.56 86.00 101.50 0.85 26.75
47.00 425.00 930.00 925.00 20.00 58.00 4544.00 82.00 96.00 0.85 25.96
48.00 280.00 675.00 675.00 18.60 55.30 4129.22 71.40 89.10 0.80 29.62
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Subject L hand vol R foot vol L foot vol Head Length Head Circ Head vol Waist hand hip hand WHR BMI
49.00 415.00 905.00 900.00 19.00 54.80 3972.08 73.00 93.40 0.78 23.59
50.00 375.00 1015.00 950.00 19.50 56.80 4344.76 73.60 94.20 0.78 21.71
51.00 425.00 975.00 1005.00 21.70 59.80 4727.11 80.00 97.10 0.82 23.74
52.00 390.00 930.00 910.00 21.40 58.40 4460.14 79.60 99.00 0.80 26.18
53.00 420.00 1000.00 945.00 19.10 56.00 4220.06 77.70 96.30 0.81 23.86
54.00 365.00 900.00 875.00 19.40 54.50 3858.30 73.60 92.50 0.80 23.63
55.00 515.00 1280.00 1280.00 19.60 56.10 4180.82 99.60 116.00 0.86 34.01
56.00 430.00 1130.00 1100.00 18.70 54.70 3986.95 76.50 93.60 0.82 24.11
57.00 480.00 925.00 905.00 19.10 55.20 4046.62 24.64
58.00 370.00 810.00 815.00 19.60 55.70 4094.10 74.50 94.50 0.79 23.72
59.00 400.00 910.00 960.00 19.50 55.50 4062.92 82.00 94.60 0.87 25.14
60.00 310.00 790.00 790.00 19.60 57.50 4484.34 81.00 97.00 0.84 22.79
62.00 365.00 850.00 810.00 19.40 56.00 4183.50 63.10 88.80 0.71 21.80
63.00 350.00 800.00 765.00 19.60 56.60 4289.22 77.50 91.10 0.85 22.32
64.00 405.00 1005.00 990.00 19.40 55.90 4161.82 76.60 97.00 0.79 23.81
65.00 490.00 1155.00 1150.00 19.33 55.66 4118.32 90.40 104.40 0.87 28.05
66.00 450.00 950.00 955.00 19.33 55.66 4118.32 80.70 94.40 0.85 23.97
67.00 285.00 780.00 810.00 19.33 55.66 4118.32 26.69
68.00 290.00 775.00 775.00 19.33 55.66 4118.32 78.60 93.20 0.84 22.61
69.00 370.00 870.00 875.00 19.33 55.66 4118.32 32.37
70.00 270.00 710.00 690.00 19.33 55.66 4118.32 74.20 84.30 0.88 19.71
71.00 255.00 805.00 800.00 19.33 55.66 4118.32 86.40 95.50 0.90 24.60
72.00 215.00 720.00 715.00 22.00 57.90 4278.64 74.20 91.80 0.81 22.15
73.00 290.00 840.00 815.00 22.00 56.80 4040.16 98.40 108.60 0.91 31.29
74.00 325.00 850.00 850.00 19.10 55.20 4046.62 75.50 94.40 0.80 20.66
75.00 305.00 875.00 980.00 19.90 56.60 4252.66 79.40 93.40 0.85 23.63
76.00 380.00 1010.00 965.00 20.00 57.40 4413.92 81.40 91.40 0.89 24.74
77.00 425.00 905.00 895.00 19.60 57.80 4549.38 91.80 101.80 0.90 30.77
78.00 465.00 1100.00 1060.00 21.00 68.70 6741.92 87.40 95.40 0.92 25.47
79.00 335.00 975.00 925.00 18.80 56.80 4430.05 82.90 100.80 0.82 25.86
80.00 360.00 870.00 815.00 18.90 55.70 4179.38 77.00 92.80 0.83 25.50
81.00 500.00 1050.00 1100.00 19.20 57.90 4619.79 97.40 112.00 0.87 30.60
82.00 430.00 930.00 930.00 20.30 57.50 4399.05 82.30 93.30 0.88 23.80
83.00 400.00 865.00 815.00 20.00 56.40 4197.12 82.10 92.10 0.89 25.76
84.00 275.00 740.00 760.00 19.10 55.10 4024.94 79.50 92.80 0.86 25.06
85.00 375.00 960.00 1005.00 20.40 55.70 3996.62 70.00 91.50 0.77 22.08
86.00 365.00 865.00 875.00 19.60 54.80 3898.98 75.10 92.60 0.81 24.85
87.00 400.00 900.00 880.00 20.40 57.60 4408.54 93.20 99.30 0.94 27.40
88.00 445.00 870.00 850.00 20.10 56.10 4119.90 82.60 99.10 0.83 26.82
89.00 340.00 920.00 920.00 19.10 56.80 4393.50 84.10 97.70 0.86 26.43
90.00 360.00 860.00 870.00 19.50 55.80 4127.96 79.60 91.40 0.87 19.53
91.00 370.00 910.00 880.00 20.20 58.30 4584.67 78.40 93.10 0.84 23.80
92.00 400.00 935.00 915.00 20.00 60.30 5042.64 76.40 94.80 0.81 22.49
93.00 350.00 950.00 910.00 19.40 56.50 4291.90 89.10 99.10 0.90 25.25
94.00 310.00 775.00 765.00 20.10 57.50 4423.42 78.10 90.10 0.87 21.41
95.00 410.00 950.00 910.00 20.50 56.90 4244.60 92.10 95.50 0.96 25.05
96.00 415.00 1065.00 1040.00 19.00 55.80 4188.88 84.60 95.70 0.88 24.23
97.00 320.00 800.00 800.00 20.20 58.60 4649.71 95.50 102.20 0.93 31.19
86 
 
Subject Scan Density BOD POD density BOD POD vol DoD equation BF scan vol (L)
1.00 1.12 1.08 80.37 12.57 78.57
2.00 1.11 1.08 81.39 14.28 79.22
3.00 1.08 1.07 78.81 16.39 79.21
4.00 1.12 7.46 63.27
5.00 1.08 1.06 83.91 16.75 82.89
6.00 1.08 1.08 75.70 75.93
7.00 1.09 1.05 102.08 20.70 98.08
8.00 1.08 1.08 70.00 8.37 70.22
9.00 1.10 1.08 71.18 7.19 68.38
10.00 1.09 1.05 78.11 17.32 76.15
11.00 1.07 1.02 124.60 54.45 119.07
12.00 1.06 1.06 76.51 16.81 76.67
13.00 1.11 1.10 66.34 14.76 65.68
14.00 1.09 1.07 82.93 11.07 81.86
15.00 1.08 1.05 73.93 14.98 72.95
16.00 1.12 1.10 50.73 6.16 50.31
17.00 1.07 1.06 99.82 19.19 99.25
18.00 1.08 1.07 81.60 12.83 81.41
19.00 1.09 1.06 77.73 15.02 75.63
20.00 0.78 1.09 59.59 18.68 81.80
21.00 1.54 1.06 83.17 4.95 57.74
22.00 1.11 1.06 71.02 16.81 69.21
23.00 1.11 1.06 77.39 10.92 75.18
24.00 1.12 1.08 66.08 9.50 64.44
25.00 1.10 1.08 62.56 8.11 61.38
26.00 1.11 1.08 67.53 10.87 66.54
27.00 1.05 1.07 64.66 15.08 65.69
28.00 1.10 1.07 112.16 14.57 109.94
29.00 1.09 1.07 79.83 14.78 78.87
30.00 1.10 1.08 64.45 10.03 63.77
31.00 0.92 1.06 69.56 16.93 80.59
32.00 1.33 1.06 82.15 14.07 66.57
33.00 1.08 1.07 73.34 12.83 73.32
34.00 1.07 1.07 75.29 10.70 76.28
35.00 1.10 4.85 63.99
36.00 1.06 1.05 85.36 22.89 84.97
37.00 1.10 1.08 79.73 9.98 78.39
38.00 1.09 1.07 76.36 13.62 75.20
39.00 1.09 1.07 69.40 12.71 68.42
40.00 1.08 1.08 68.96 11.75 69.13
41.00 1.12 1.08 69.89 10.41 67.67
42.00 1.09 1.07 70.52 9.40 69.53
43.00 1.10 1.07 75.63 10.84 74.33
44.00 1.09 1.09 80.94 11.96 81.18
45.00 1.10 1.08 80.55 11.26 79.70
46.00 0.99 1.08 72.76 14.88 79.70
47.00 1.11 1.07 74.99 11.47 72.92
48.00 0.78 1.09 72.76 7.99 75.75  
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Subject Scan Density BOD POD density BOD POD vol DoD equation BF scan vol (L)
49.00 1.50 1.10 72.70 7.28 53.42
50.00 1.01 1.08 67.39 9.07 72.60
51.00 1.18 1.07 72.99 11.55 66.85
52.00 1.12 1.08 74.70 11.10 72.65
53.00 1.10 1.07 74.98 8.41 73.56
54.00 0.99 1.09 68.00 5.35 75.02
55.00 1.74 1.05 111.86 22.54 67.63
56.00 0.71 1.08 72.33 9.30 110.29
57.00 1.02 1.09 65.66 11.84 71.75
58.00 1.09 1.09 66.34 6.43 65.78
59.00 1.15 1.09 68.62 9.36 65.48
60.00 1.02 1.07 65.29 13.33 68.70
62.00 1.10 1.08 62.91 7.27 62.18
63.00 1.10 1.09 63.70 8.10 63.24
64.00 1.10 1.07 70.86 10.36 69.59
65.00 1.07 1.08 92.48 18.89 94.05
66.00 1.13 1.09 71.01 10.36 69.17
67.00 1.09 1.04 72.66 16.17 69.61
68.00 1.08 1.08 64.74 14.50 65.08
69.00 1.05 1.03 100.51 17.95 99.33
70.00 1.07 1.08 61.09 33.26 61.79
71.00 1.10 1.07 74.15 9.14 72.91
72.00 1.11 1.09 60.69 8.03 60.58
73.00 1.07 1.02 94.87 21.48 91.24
74.00 1.09 1.07 63.79 7.96 63.23
75.00 1.11 1.08 67.62 10.69 66.12
76.00 1.08 1.08 74.35 14.43 74.76
77.00 1.07 1.05 84.74 18.06 84.17
78.00 1.10 1.07 85.34 17.21 83.70
79.00 1.09 1.04 73.44 14.73 70.21
80.00 1.12 1.07 68.67 11.07 65.92
81.00 1.07 1.05 95.65 25.18 94.22
82.00 1.09 1.10 74.36 15.66 75.07
83.00 1.08 1.07 83.46 13.40 82.98
84.00 1.07 1.10 61.09 17.29 63.03
85.00 1.07 1.09 65.50 8.43 67.05
86.00 1.11 1.08 65.22 10.65 63.81
87.00 1.07 1.05 87.35 19.43 86.50
88.00 1.09 1.08 78.21 12.93 78.04
89.00 1.09 1.05 75.61 16.42 73.66
90.00 1.06 1.07 66.31 8.60 67.58
91.00 1.09 1.08 67.72 10.68 67.72
92.00 1.11 1.09 68.92 7.25 67.99
93.00 1.08 1.07 80.70 15.11 80.54
94.00 1.10 1.09 65.33 9.70 65.24
95.00 1.09 1.07 73.26 13.03 71.90
96.00 1.10 1.09 74.95 12.07 74.92
97.00 1.09 17.79 91.64  
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Subject Ab Scan (cm) Waist Scan (cm) Hip Scan (cm)
1.00 75.62 76.93 100.71
2.00 80.72 72.57 94.07
3.00 78.59 79.50 99.36
4.00 78.17 77.61 97.05
5.00 85.30 82.61 96.77
6.00 80.21 80.07 92.08
7.00 79.79 77.10 95.66
8.00 76.82 76.58 93.12
9.00 80.06 77.83 98.20
10.00 82.62 82.07 96.77
11.00 88.25 72.71 91.05
12.00 83.10 80.82 98.57
13.00 84.99 83.58 100.67
14.00 94.02 77.89 101.23
15.00 92.93 80.76 97.58
16.00 86.09 75.37 100.45
17.00 85.89 83.73 103.45
18.00 84.70 83.84 98.35
19.00 83.11 81.67 105.46
20.00 83.12 83.09 100.55
21.00 83.82 80.91 96.55
22.00 87.06 85.38 106.23
23.00 94.64 80.88 97.14
24.00 84.41 83.33 99.15
25.00 84.55 84.07 102.46
26.00 82.08 81.51 99.74
27.00 82.57 81.73 99.94
28.00 86.15 82.81 99.56
29.00 85.80 83.68 99.63
30.00 83.38 81.77 104.10
31.00 89.37 87.04 106.04
32.00 84.36 84.50 99.51
33.00 93.90 88.59 103.29
34.00 83.14 82.99 101.27
35.00 90.83 89.57 105.48
36.00 90.97 86.07 103.31
37.00 87.59 82.74 103.36
38.00 89.70 88.48 103.25
39.00 82.61 83.21 100.77
40.00 83.26 82.74 99.41
41.00 90.17 89.70 102.77
42.00 86.23 86.68 102.39
43.00 85.03 83.42 103.15
44.00 86.33 85.15 99.12
45.00 94.55 91.58 107.49
46.00 88.29 86.45 104.67
47.00 89.19 88.39 106.91
48.00 89.01 88.16 100.75  
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Subject Ab Scan (cm) Waist Scan (cm) Hip Scan (cm)
49.00 86.38 84.02 101.64
50.00 90.77 91.15 107.97
51.00 80.40 78.99 100.23
52.00 102.20 87.84 105.82
53.00 90.56 89.18 101.92
54.00 98.76 87.78 101.91
55.00 117.43 95.07 121.04
56.00 89.04 86.51 104.52
57.00 78.97 78.66 92.89
58.00 91.43 91.02 102.37
59.00 88.84 85.83 103.18
60.00 90.99 89.42 104.41
62.00 105.95 85.71 110.54
63.00 87.54 86.60 99.29
64.00 104.63 91.44 105.34
65.00 84.74 84.52 101.60
66.00 101.01 87.29 102.59
67.00 103.13 91.14 104.57
68.00 86.85 87.39 106.60
69.00 103.56 95.17 106.47
70.00 97.04 87.64 99.81
71.00 94.15 92.98 108.29
72.00 90.35 90.58 104.89
73.00 88.58 85.32 102.66
74.00 100.59 93.84 104.48
75.00 97.54 93.41 112.83
76.00 107.03 99.16 117.14
77.00 105.76 93.60 107.44
78.00 99.18 95.94 108.80
79.00 107.40 103.51 109.76
80.00 98.25 97.46 100.90
81.00 105.19 101.15 116.87
82.00 113.02 105.29 113.65
83.00 106.71 104.99 109.58
84.00 112.66 100.88 115.03
85.00 79.72 80.51 91.30
86.00 127.95 126.43 129.61  
 
 
 
 
